Table 1 Transcription factors predicted to interact with phosphoproteins found in MS experiments
BARD1 | BRCA1 associated RING domain 1 |
BMI1 | BMI1 polycomb ring finger oncogene |
CBX3 | Chromobox homolog 3 |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88Â kDa |
HIC1 | Hypermethylated in cancer 1 |
HMGA1 | High mobility group AT-hook 1 |
HNF4A | Hepatocyte nuclear factor 4, alpha |
ID3 | Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
KDM5B | Lysine (K)-specific demethylase 5B |
MAZ | MYC-associated zinc finger protein (purine-binding transcription factor) |
MTA1 | Metastasis associated 1 |
MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
NFATC1 | Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
PPP1R13L | Protein phosphatase 1, regulatory (inhibitor) subunit 13 like |
SIAH2 | Seven in absentia homolog 2 (Drosophila) |
SMAD3 | SMAD family member 3 |
SOX4 | SRY (sex determining region Y)-box 4 |
SP1 | Sp1 transcription factor |
SREBF1 | Sterol regulatory element binding transcription factor 1 |
TFDP1 | Transcription factor Dp-1 |
TGFB1I1 | Transforming growth factor beta 1 induced transcript 1 |
TLE1 | Transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) |
YAP1 | Yes-associated protein 1 |
CBX4 | Chromobox homolog 4 |
E2F4 | E2F transcription factor 4, p107/p130-binding |